Status:

UNKNOWN

Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension.

Lead Sponsor:

University of Nove de Julho

Collaborating Sponsors:

University of Miami

Faculdade de Ciências Médicas da Santa Casa de São Paulo

Conditions:

Pulmonary Arterial Hypertension

Cardiovascular Diseases

Eligibility:

All Genders

20-70 years

Phase:

NA

Brief Summary

Although there has been some progress in pharmacological management of PAH, limited functional capacity and low survival still persist, but there is evidence that exercise training can be accomplished...

Detailed Description

Pulmonary arterial hypertension (PAH) is characterized by pathological changes in the pulmonary vasculature which cause an increase in pulmonary vascular resistance (PVR), restricting the flow of bloo...

Eligibility Criteria

Inclusion

  • Having confirmed diagnosis of PAH, based on elevated pressure in the pulmonary artery measured by catheterization of the heart at rest, with WHO functional (World Health Organization's - Functional Assessment for Pulmonary Hypertension - modified after New York Heart Association Functional Classification (NYHA) functional classification) classes I, II, III or IV to capture PAH patients with pré-capillary involvement;
  • Clinically stable with no previous hospitalizations in the last four weeks;
  • Receiving PAH specific drug therapy for at least 3 months before the study began.

Exclusion

  • Use of continuous oxygen therapy;
  • Significant musculoskeletal disease or pain / claudication members;
  • Neurologic or cognitive impairment, psychiatric disorders or psychological mood (making it difficult for patients to understand the required tests);
  • History of moderate or severe chronic lung disease;
  • PAH patients with post-capillary involvement.
  • Cardiac disease associated with cardiac failure, angina and / or unstable heart rhythm.

Key Trial Info

Start Date :

January 10 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 10 2020

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT03476629

Start Date

January 10 2016

End Date

December 10 2020

Last Update

November 4 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Santa Casa de São Paulo Hospital

São Paulo, São Paulo, Brazil